A simple novel method for determining mortality rates in HIV treatment programs worldwide.
In this Perspective, Gregory Bisson discusses a new article by Matthias Egger and colleagues that introduces a simple method for HIV treatment programs to more accurately estimate the proportion of patients dying in the first year after ART initiation.
University of Pennsylvania School of Medicine, Philadelphia, PA, USA. bisson@mail.med.upenn.edu
Gregory P
GP
Bisson
D000465:Algorithms; D019380:Anti-HIV Agents / Q000627:therapeutic use; D014943:Global Health; D015658:HIV Infections / Q000188:drug therapy / Q000401:mortality*; D006801:Humans; D009026:Mortality / Q000639:trends; D010352:Patient Dropouts / Q000706:statistics & numerical data*; D015397:Program Evaluation / Q000706:statistics & numerical data*
D019380:Anti-HIV Agents
PLoS One. 2008 Mar 05;3(3):e1725
18320045
PLoS Med. 2007 Oct 16;4(10):e298
17941716
Trop Med Int Health. 2010 Jun;15 Suppl 1:98-104
20586967
PLoS One. 2009 Jun 04;4(6):e5790
19495419
Am J Epidemiol. 2010 Apr 15;171(8):924-31
20219765
AIDS Behav. 2010 Dec;14(6):1340-6
20809380
JAMA. 2006 Aug 16;296(7):782-93
16905784
PLoS Med. 2011 Jan 18;8(1):e1000390
21267057
J Acquir Immune Defic Syndr. 2010 Mar;53(3):405-11
19745753
J Acquir Immune Defic Syndr. 2004 Mar 1;35(3):320-3
15076249